Sam Brusco, Associate Editor05.16.23
Intuitive has enacted executive leadership changes, promoting Dave Rosa to the role of president.
Rosa will lead the company’s digital, quality, regulatory, supply chain, manufacturing, and commercial teams. He will also oversee the company’s core business.
Rosa is a 27-year Intuitive veteran who had key leadership roles across the business in the commercial, engineering, clinical development, marketing, and product development organizations. Most recently, he served as executive VP and chief strategy and growth officer.
“As Intuitive has grown and demand for robotic-assisted surgery has increased, we remain focused on our mission to advance minimally invasive care and our commitment to working with customers to meaningfully improve patient outcomes,” Intuitive CEO Gary Guthart told the press. “Aligning our core business functions under Dave, a proven and outstanding leader with broad and deep experience across Intuitive, equips us to meet future opportunities to collaborate with hospitals and healthcare systems to address healthcare challenges at significant scale.”
“Our efforts over the past 27 years have created great opportunities to serve our customers better and in new ways. I look forward to leading our continued development of innovative, outcomes-focused products, services, and solutions,” added Rosa. “Intuitive aims to deliver excellence in customer experience, industry-leading innovation, and meaningful expansion of minimally invasive care. My goal is to help the company continue to deliver on these aims.”
Guthart will continue to be Intuitive’s CEO, leading the company and focusing on its presence in the market, overall strategy, governance, and culture. Guthart has also been with Intuitive for 27 years and has been CEO since 2010.
Further, Bob DeSantis will assume the newly created role of executive VP and chief strategy and corporate operations officer. Previously, DeSantis was executive VP and chief product officer. He has spent a decade with Intuitive.
Earlier this month, Intuitive’s da Vinci SP (single port) surgical system was cleared by the FDA to perform simple prostatectomy as a representative procedure.
Rosa will lead the company’s digital, quality, regulatory, supply chain, manufacturing, and commercial teams. He will also oversee the company’s core business.
Rosa is a 27-year Intuitive veteran who had key leadership roles across the business in the commercial, engineering, clinical development, marketing, and product development organizations. Most recently, he served as executive VP and chief strategy and growth officer.
“As Intuitive has grown and demand for robotic-assisted surgery has increased, we remain focused on our mission to advance minimally invasive care and our commitment to working with customers to meaningfully improve patient outcomes,” Intuitive CEO Gary Guthart told the press. “Aligning our core business functions under Dave, a proven and outstanding leader with broad and deep experience across Intuitive, equips us to meet future opportunities to collaborate with hospitals and healthcare systems to address healthcare challenges at significant scale.”
“Our efforts over the past 27 years have created great opportunities to serve our customers better and in new ways. I look forward to leading our continued development of innovative, outcomes-focused products, services, and solutions,” added Rosa. “Intuitive aims to deliver excellence in customer experience, industry-leading innovation, and meaningful expansion of minimally invasive care. My goal is to help the company continue to deliver on these aims.”
Guthart will continue to be Intuitive’s CEO, leading the company and focusing on its presence in the market, overall strategy, governance, and culture. Guthart has also been with Intuitive for 27 years and has been CEO since 2010.
Further, Bob DeSantis will assume the newly created role of executive VP and chief strategy and corporate operations officer. Previously, DeSantis was executive VP and chief product officer. He has spent a decade with Intuitive.
Earlier this month, Intuitive’s da Vinci SP (single port) surgical system was cleared by the FDA to perform simple prostatectomy as a representative procedure.